PRIORITY-B (COVID-19 Biospecimens)



The Gaw Lab heads PRIORITY-B, the COVID-19 biorepository that enrolls in parallel with the national PRIORITY Registry ( 

We are enrolling mother-infant dyads from pregnancies affected by COVID-19 from specific sites across the country.  

With these biologic samples, we are studying the impact of SARS-CoV-2 on the pregnant mother and developing baby. We hope to understand how the maternal and fetal immune systems respond to infection, and how they prevent transmission across the placenta, and modulate clinical disease and pregnancy outcomes.​ These studies are important to understand how to best care for pregnancies affected by COVID-19, and the results will guide treatment and vaccination strategies in this vulnerable population. ​






Click here to contact the Gaw Lab. 

Follow us on Twitter @gaw_lab